- Home
- WTBA vs ZURA Comparison
WTBA vs ZURA Comparison
Compare WTBA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTBA
- ZURA
- Stock Information
- Founded
- WTBA 1893
- ZURA 2022
- Country
- WTBA United States
- ZURA United States
- Employees
- WTBA N/A
- ZURA N/A
- Industry
- WTBA Major Banks
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WTBA Finance
- ZURA Health Care
- Exchange
- WTBA Nasdaq
- ZURA Nasdaq
- Market Cap
- WTBA 331.2M
- ZURA 69.9M
- IPO Year
- WTBA N/A
- ZURA N/A
- Fundamental
- Price
- WTBA $20.23
- ZURA $1.31
- Analyst Decision
- WTBA Hold
- ZURA Buy
- Analyst Count
- WTBA 1
- ZURA 7
- Target Price
- WTBA $23.00
- ZURA $14.33
- AVG Volume (30 Days)
- WTBA 31.7K
- ZURA 712.2K
- Earning Date
- WTBA 07-24-2025
- ZURA 08-08-2025
- Dividend Yield
- WTBA 4.83%
- ZURA N/A
- EPS Growth
- WTBA 15.99
- ZURA N/A
- EPS
- WTBA 1.53
- ZURA N/A
- Revenue
- WTBA $82,845,000.00
- ZURA N/A
- Revenue This Year
- WTBA $23.88
- ZURA N/A
- Revenue Next Year
- WTBA $10.37
- ZURA N/A
- P/E Ratio
- WTBA $13.21
- ZURA N/A
- Revenue Growth
- WTBA 9.30
- ZURA N/A
- 52 Week Low
- WTBA $17.33
- ZURA $0.97
- 52 Week High
- WTBA $24.85
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- WTBA 53.66
- ZURA 59.63
- Support Level
- WTBA $20.47
- ZURA $1.00
- Resistance Level
- WTBA $21.02
- ZURA $1.45
- Average True Range (ATR)
- WTBA 0.55
- ZURA 0.10
- MACD
- WTBA 0.09
- ZURA 0.03
- Stochastic Oscillator
- WTBA 49.83
- ZURA 68.89
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.